Pharma Journalist -

Armas Pharmaceuticals Inc. and Micro Labs USA, Inc. have announced, the forming of a strategic collaboration to bring select multisource injectable products to the U.S. market. The…
Read More...

Allergan plc and Gedeon Richter Plc. announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for…
Read More...

Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private…
Read More...

Acerus Pharmaceuticals Corporation announced that it has signed a patent license agreement with the University of Texas at Austin for technology related to the nasal administration of…
Read More...

Modulus Discovery, an early stage global biopharmaceutical company, announced the signing of research data transfer agreement on a specific drug target with Astellas Pharma. Under…
Read More...

Epizyme, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for accelerated approval of tazemetostat for the treatment of…
Read More...

Imara, Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies, announced that the U.S. Food and Drug Administration (FDA) has…
Read More...

AgilVax, Inc., a biotechnology company developing targeted antibody-based therapies for the treatment of various cancers, including metastatic breast cancer (MBC), announced that the…
Read More...

Prestige BioPharma announced that European Medicines Agency (EMA) has validated and accepted for review the Marketing Authorization Application (MAA) for its trastuzumab biosimilar…
Read More...

Vetter has reached another important milestone regarding sustainability. Beginning immediately, all German sites of the company will be supplied with only CO2 neutral energy from…
Read More...